CA Stock MarketDetailed Quotes

BCT BriaCell Therapeutics Corp

Watchlist
  • 0.950
  • -0.060-5.94%
15min DelayTrading Nov 25 14:44 ET
34.37MMarket Cap-2375P/E (TTM)

BriaCell Therapeutics Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jul 31, 2024
(Q4)Jul 31, 2024
(Q3)Apr 30, 2024
(Q2)Jan 31, 2024
(Q1)Oct 31, 2023
(FY)Jul 31, 2023
(Q4)Jul 31, 2023
(Q3)Apr 30, 2023
(Q2)Jan 31, 2023
(Q1)Oct 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
43.22%33.33M
-25.15%5.77M
62.58%9.23M
119.10%9.83M
57.37%8.5M
52.25%23.27M
47.22%7.71M
37.68%5.68M
23.13%4.49M
136.48%5.4M
Selling and administrative expenses
-22.47%6.15M
-46.32%1.36M
-13.46%1.57M
9.70%1.57M
-23.38%1.65M
9.19%7.94M
22.91%2.54M
-2.05%1.82M
-26.08%1.43M
52.43%2.15M
-General and administrative expense
-22.47%6.15M
-46.32%1.36M
-13.46%1.57M
9.70%1.57M
-23.38%1.65M
9.19%7.94M
22.91%2.54M
-2.05%1.82M
-26.08%1.43M
52.43%2.15M
Research and development costs
77.21%27.18M
-14.75%4.41M
98.36%7.66M
170.44%8.26M
110.65%6.86M
91.19%15.34M
63.07%5.17M
70.16%3.86M
78.75%3.05M
271.75%3.26M
Operating profit
-43.22%-33.33M
25.15%-5.77M
-62.58%-9.23M
-119.10%-9.83M
-57.37%-8.5M
-52.25%-23.27M
-47.22%-7.71M
-37.68%-5.68M
-23.13%-4.49M
-136.48%-5.4M
Net non-operating interest income (expenses)
-67.68%288.02K
-100.00%2
-93.84%15.61K
-66.09%81.6K
1.31%190.82K
556.50%891.21K
153.50%208.78K
604.39%253.49K
1,891.52%240.6K
3,436.48%188.35K
Non-operating interest income
-67.68%288.02K
-100.00%2
-93.84%15.61K
-66.09%81.6K
1.31%190.82K
551.80%891.21K
153.50%208.78K
604.39%253.49K
1,891.52%240.6K
2,887.36%188.35K
Other net income (expenses)
1,252.34%28.11M
-11.01%4.52M
1,965.18%10.91M
79.23%-1.59M
247.38%14.27M
117.78%2.08M
8.02%5.08M
108.91%528.1K
-151.62%-7.64M
116.27%4.11M
Gain on sale of security
1,257.46%28.22M
-10.00%4.57M
1,972.18%10.94M
79.47%-1.57M
247.38%14.27M
117.78%2.08M
8.02%5.08M
108.91%528.1K
-151.62%-7.64M
116.27%4.11M
Income before tax
75.71%-4.93M
48.37%-1.25M
134.57%1.69M
4.61%-11.33M
638.51%5.96M
24.35%-20.3M
-437.06%-2.42M
51.12%-4.9M
-206.46%-11.88M
95.98%-1.11M
Income tax
Earnings from equity interest net of tax
Net income
75.71%-4.93M
48.37%-1.25M
134.57%1.69M
4.61%-11.33M
638.51%5.96M
24.35%-20.3M
-437.06%-2.42M
51.12%-4.9M
-206.46%-11.88M
95.98%-1.11M
Net income continuous operations
75.71%-4.93M
48.37%-1.25M
134.57%1.69M
4.61%-11.33M
638.51%5.96M
24.35%-20.3M
-437.06%-2.42M
51.12%-4.9M
-206.46%-11.88M
95.98%-1.11M
Noncontrolling interests
-140.08K
-34.59K
-23.52K
-39.31K
-42.67K
0
0
0
0
0
Net income attributable to the company
76.40%-4.79M
49.80%-1.21M
135.05%1.72M
4.94%-11.29M
642.37%6M
24.35%-20.3M
-437.06%-2.42M
51.12%-4.9M
-206.46%-11.88M
95.98%-1.11M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
76.40%-4.79M
49.80%-1.21M
135.05%1.72M
4.94%-11.29M
642.37%6M
24.35%-20.3M
-437.06%-2.42M
51.12%-4.9M
-206.46%-11.88M
95.98%-1.11M
Diluted earnings per share
77.69%-0.29
53.33%-0.07
134.38%0.11
7.79%-0.71
642.86%0.38
24.86%-1.3
-400.00%-0.15
50.77%-0.32
-208.45%-0.77
96.13%-0.07
Basic earnings per share
77.69%-0.29
53.33%-0.07
134.38%0.11
7.79%-0.71
-614.29%-0.5
24.86%-1.3
-400.00%-0.15
50.77%-0.32
-208.45%-0.77
96.13%-0.07
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Jul 31, 2024(Q4)Jul 31, 2024(Q3)Apr 30, 2024(Q2)Jan 31, 2024(Q1)Oct 31, 2023(FY)Jul 31, 2023(Q4)Jul 31, 2023(Q3)Apr 30, 2023(Q2)Jan 31, 2023(Q1)Oct 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 43.22%33.33M-25.15%5.77M62.58%9.23M119.10%9.83M57.37%8.5M52.25%23.27M47.22%7.71M37.68%5.68M23.13%4.49M136.48%5.4M
Selling and administrative expenses -22.47%6.15M-46.32%1.36M-13.46%1.57M9.70%1.57M-23.38%1.65M9.19%7.94M22.91%2.54M-2.05%1.82M-26.08%1.43M52.43%2.15M
-General and administrative expense -22.47%6.15M-46.32%1.36M-13.46%1.57M9.70%1.57M-23.38%1.65M9.19%7.94M22.91%2.54M-2.05%1.82M-26.08%1.43M52.43%2.15M
Research and development costs 77.21%27.18M-14.75%4.41M98.36%7.66M170.44%8.26M110.65%6.86M91.19%15.34M63.07%5.17M70.16%3.86M78.75%3.05M271.75%3.26M
Operating profit -43.22%-33.33M25.15%-5.77M-62.58%-9.23M-119.10%-9.83M-57.37%-8.5M-52.25%-23.27M-47.22%-7.71M-37.68%-5.68M-23.13%-4.49M-136.48%-5.4M
Net non-operating interest income (expenses) -67.68%288.02K-100.00%2-93.84%15.61K-66.09%81.6K1.31%190.82K556.50%891.21K153.50%208.78K604.39%253.49K1,891.52%240.6K3,436.48%188.35K
Non-operating interest income -67.68%288.02K-100.00%2-93.84%15.61K-66.09%81.6K1.31%190.82K551.80%891.21K153.50%208.78K604.39%253.49K1,891.52%240.6K2,887.36%188.35K
Other net income (expenses) 1,252.34%28.11M-11.01%4.52M1,965.18%10.91M79.23%-1.59M247.38%14.27M117.78%2.08M8.02%5.08M108.91%528.1K-151.62%-7.64M116.27%4.11M
Gain on sale of security 1,257.46%28.22M-10.00%4.57M1,972.18%10.94M79.47%-1.57M247.38%14.27M117.78%2.08M8.02%5.08M108.91%528.1K-151.62%-7.64M116.27%4.11M
Income before tax 75.71%-4.93M48.37%-1.25M134.57%1.69M4.61%-11.33M638.51%5.96M24.35%-20.3M-437.06%-2.42M51.12%-4.9M-206.46%-11.88M95.98%-1.11M
Income tax
Earnings from equity interest net of tax
Net income 75.71%-4.93M48.37%-1.25M134.57%1.69M4.61%-11.33M638.51%5.96M24.35%-20.3M-437.06%-2.42M51.12%-4.9M-206.46%-11.88M95.98%-1.11M
Net income continuous operations 75.71%-4.93M48.37%-1.25M134.57%1.69M4.61%-11.33M638.51%5.96M24.35%-20.3M-437.06%-2.42M51.12%-4.9M-206.46%-11.88M95.98%-1.11M
Noncontrolling interests -140.08K-34.59K-23.52K-39.31K-42.67K00000
Net income attributable to the company 76.40%-4.79M49.80%-1.21M135.05%1.72M4.94%-11.29M642.37%6M24.35%-20.3M-437.06%-2.42M51.12%-4.9M-206.46%-11.88M95.98%-1.11M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 76.40%-4.79M49.80%-1.21M135.05%1.72M4.94%-11.29M642.37%6M24.35%-20.3M-437.06%-2.42M51.12%-4.9M-206.46%-11.88M95.98%-1.11M
Diluted earnings per share 77.69%-0.2953.33%-0.07134.38%0.117.79%-0.71642.86%0.3824.86%-1.3-400.00%-0.1550.77%-0.32-208.45%-0.7796.13%-0.07
Basic earnings per share 77.69%-0.2953.33%-0.07134.38%0.117.79%-0.71-614.29%-0.524.86%-1.3-400.00%-0.1550.77%-0.32-208.45%-0.7796.13%-0.07
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data